1. Antibodies and Reagents
2. Apoptosis and Cell Health Reagents
3. Buffers and Chemical Probes
4. Clinical | Analyte Specific Reagents (ASR)
5. Isotype Controls
6. Magnetic Separation - MojoSort™
7. Non-Human Primate Antibodies
8. Recombinant Proteins, C

1. Gut Health and Colorectal Cancer Methylation Test
2. Congenital Risk and Trait Assessment
3. AccuGen® Health GeneTech Corp. Common Pathogenic Microorganism Detection
4. Gut Microbiota Test
5. Highly Customized Bioinformatics Analysis Services
6. Professional OEM Services: Illumina Microarrays, Illumina Sequencing, Nanopore Sequencing

PERSONAL GENOMICS TAIWAN, INC. is primarily commissioned by Personal Genomics, Inc. (PGI) to conduct the research and development of compact nucleic acid sequencing platforms for clinical diagnosis. Its business areas include:

1. OES Single-Molecule Sequencer Development: This sequencer utilizes the principle of continuous single-molecule sequencing by synthesis, integrating technologies such as nano-optical chips, solid-phase single-molecule biochemical reactions, and single-molecule fluorescence cameras to develop a nucleic acid sequencer suitable for clinical diagnostic testing.

2. Single-Molecule Sequencing Chemical Enzyme and Reagent Development: Utilizing enzyme engineering methods to screen high-activity enzymes for specially designed fluorescently labeled nucleotides, and developing them into sequencing reagents and consumables.

SYNCELL’s flagship technology is the Microscoop™ system — a high-content, microscope-based platform that couples AI-driven image recognition with proprietary photosensitive labeling reagents to tag and selectively isolate proteins and nucleic acids from u